Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients

Digestive Diseases

Volumn 27, Issue 1, 2009, Pages 68-73

  Weigt, Jochen ^a   Kandulski, Arne ^a   Büsch, Franziska ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Gastroesophageal reflux disease; Impedance; Nocturnal acid breakthrough; PH metry; Proton pump inhibitors

Indexed keywords

ESOMEPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE;

ADULT; AGED; ALKALINITY; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; PH MEASUREMENT; PRIORITY JOURNAL; RECORDING; STANDING; STOMACH ACID; STOMACH PH;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL PH MONITORING; ESOPHAGUS; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTRIC MUCOSA; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MANOMETRY; MIDDLE AGED; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 65949090292     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210107     Document Type: Article

References (21)

1. Peghini PL, Katz PO, Bracy NA, Castell DO: Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol 1998; 93:763-767.
2. Peghini PL, Katz PO, Castell DO: Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology 1998; 115:1335-1339.
3. Katz PO, Anderson C, Khoury R, Castell DO: Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors. Aliment Pharmacol Ther 1998; 12:1231-1234.
4. Hatlebakk JG, Katz PO, Kuo B, Castell DO: Nocturnal gastric acidity and acid breakthrough on different regimens of omepra-zole 40 mg daily. Aliment Pharmacol Ther 1998; 12:1235-1240.
5. Xue S, Katz PO, Banerjee P, Tutuian R, Cas-tell DO: Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther 2001; 15:1351-1356.
6. Ours TM, Fackler WK, Richter JE, Vaezi MF: Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am J Gastroenterol 2003; 98: 545-550.
7. Tutuian R, Castell DO: Reflux monitoring: role of combined multichannel intraluminal impedance and pH. Gastrointest Endosc Clin North Am 2005; 15:361-371.
8. Castell DO, Vela M: Combined multichannel intraluminal impedance and pH-metry: an evolving technique to measure type and proximal extent of gastroesophageal reflux. Am J Med 2001; 111(suppl 8A):157S-159S.
9. Tamhankar AP, Peters JH, Portale G, Hsieh CC, Hagen JA, Bremner CG, DeMeester TR: Omeprazole does not reduce gastroesopha-geal reflux: new insights using multichannel intraluminal impedance technology. J Gas-trointest Surg 2004; 8:890-897; discussion 897-898.
10. Weigt J, Mönkemüller K, Peitz U, Malfert-heiner P: Multichannel intraluminal impedance and pH-metry for investigation of symptomatic gastroesophageal reflux disease. Dig Dis 2007; 25:179-182.
11. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R: The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101:1900-1920; quiz 1943.
12. Shay S, Tutuian R, Sifrim D, Vela M, Wise J, Balaji N, Zhang X, Adhami T, Murray J, Peters J, Castell D: Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroen-terol 2004; 99:1037-1043.
13. Sifrim D, Holloway R, Silny J, Xin Z, Tack J, Lerut A, Janssens J: Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology 2001; 120:1588-1598.
14. Tutuian R, Elton JP, Castell DO, Gideon RM, Castell JA, Katz PO: Effects of position on oesophageal function: studies using combined manometry and multichannel intralu-minal impedance. Neurogastroenterol Motil 2003; 15:63-67.
15. Weigt J, Büsch F, Mönkemüller K, Malfert-heiner P: Analysis of gasto-oesophageal reflux patterns in dependency of body posture using combined multichannel intraluminal impedance and pH-metry. Gut 2007; 56 (suppl III):A207.
16. Zerbib F, des Varannes SB, Roman S, Pou-derou x P, Ar t ig ue F, Chaput U, Mion F, Ca il-lol F, Ver i n E , Bommelaer G, Ducrot te P, Ga l-miche JP, Sifrim D: Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 2005; 22:1011-1021.
17. Nzeako UC, Murray JA: An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy. Aliment Pharmacol Ther 2002; 16:1309-1316.
18. Lopez-Alonso M, Moya MJ, Cabo JA, Ribas J, del Carmen Macias M, Silny J, Sifrim D: Twent y-fou r-hou r esophage a l i mp ed a nce-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux. Pediatrics 2006; 118:e299-e308.
19. Ghoshal UC, Chourasia D, Tripathi S, Misra A, Singh K: Relationship of severity of gas-troesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry. Scand J Gastroenterol 2008; 43: 654-661.
20. Johnston DA, Wormsley KG: Problems with the interpretation of gastric pH measurement. Clin Invest ig 1993; 72: 12-17.
21. Holloway RH, Sifrim DA: The acid pocket and its relevance to reflux disease. Gut 2008; 57:285-286.